Pitney Bowes adds La Vonda Williams to Board, assigns to Strategic Review Committee

Filed July 27, 2026 · Period ending July 21, 2026 · ~1 min read

Key Changes

• medium

  La Vonda Williams appointed to Board effective July 21, 2026, with assignment to Strategic Review Committee alongside Audit and Governance committees.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• medium

  Williams brings nearly 20 years of finance and operations leadership, including prior CFO role at Onegevity Health and VP position at Goldman Sachs.

  Exhibit 99.1 view on EDGAR →
• low

  Compensation includes $200,000 annual cash retainer, $32,000 in committee retainers, and equity grants totaling $306,541 (prorated for mid-year start).

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →